D
AngioDynamics, Inc.
ANGO
$9.66
$0.272.88%
D
Sell
10/4/2024Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D- from E+ on 10/4/2024 due to an increase in the total return index, valuation index and efficiency index. Net income increased 4.84% from -$13.45M to -$12.8M.
AngioDynamics, Inc. (ANGO) was upgraded to D- from E+ on 10/4/2024 due to an increase in the total return index, valuation index and efficiency index. Net income increased 4.84% from -$13.45M to -$12.8M.
E
Sell
1/9/2024Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to E+ from D on 1/9/2024 due to a substantial decline in the efficiency index, valuation index and growth index. Net income declined 163.31% from $45.88M to -$29.05M, earnings per share declined from $1.15 to -$0.7222, and total capital declined 6.26% from $432.5M to $405.45M.
AngioDynamics, Inc. (ANGO) was downgraded to E+ from D on 1/9/2024 due to a substantial decline in the efficiency index, valuation index and growth index. Net income declined 163.31% from $45.88M to -$29.05M, earnings per share declined from $1.15 to -$0.7222, and total capital declined 6.26% from $432.5M to $405.45M.
D
Sell
10/6/2023Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D from E+ on 10/6/2023 due to a substantial increase in the efficiency index, valuation index and solvency index. Net income increased 313.74% from -$21.47M to $45.88M, debt to equity declined from 0.14 to 0, and the quick ratio increased from 1.16 to 1.87.
AngioDynamics, Inc. (ANGO) was upgraded to D from E+ on 10/6/2023 due to a substantial increase in the efficiency index, valuation index and solvency index. Net income increased 313.74% from -$21.47M to $45.88M, debt to equity declined from 0.14 to 0, and the quick ratio increased from 1.16 to 1.87.
E
Sell
3/16/2023Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to E+ from D- on 3/16/2023 due to a decline in the volatility index.
AngioDynamics, Inc. (ANGO) was downgraded to E+ from D- on 3/16/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D- from D on 03/14/2023.
AngioDynamics, Inc. (ANGO) was downgraded to D- from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D from E+ on 02/09/2023.
AngioDynamics, Inc. (ANGO) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to E+ from D on 2/8/2023 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.18 to 1.12.
AngioDynamics, Inc. (ANGO) was downgraded to E+ from D on 2/8/2023 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.18 to 1.12.
D
Sell
10/12/2022Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D from D+ on 10/12/2022 due to a large decline in the solvency index, growth index and volatility index. Operating cash flow declined 389.08% from $8.56M to -$24.75M, debt to equity increased from 0.06 to 0.13, and earnings per share declined from -$0.1601 to -$0.3309.
AngioDynamics, Inc. (ANGO) was downgraded to D from D+ on 10/12/2022 due to a large decline in the solvency index, growth index and volatility index. Operating cash flow declined 389.08% from $8.56M to -$24.75M, debt to equity increased from 0.06 to 0.13, and earnings per share declined from -$0.1601 to -$0.3309.
D
Sell
8/18/2022Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D on 8/18/2022 due to an increase in the volatility index.
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D on 8/18/2022 due to an increase in the volatility index.
D
Sell
8/3/2022Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D from D+ on 8/3/2022 due to a substantial decline in the growth index and valuation index. Earnings per share declined from -$0.13 to -$0.1601, and EBIT declined 9.73% from -$6.84M to -$7.5M.
AngioDynamics, Inc. (ANGO) was downgraded to D from D+ on 8/3/2022 due to a substantial decline in the growth index and valuation index. Earnings per share declined from -$0.13 to -$0.1601, and EBIT declined 9.73% from -$6.84M to -$7.5M.
D
Sell
5/16/2022Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 05/16/2022.
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 05/16/2022.
D
Sell
5/13/2022Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 5/13/2022 due to a decline in the total return index and volatility index.
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/4/2022Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 5/4/2022 due to an increase in the total return index and valuation index.
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 5/4/2022 due to an increase in the total return index and valuation index.
D
Sell
5/1/2022Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 05/01/2022.
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 05/01/2022.
D
Sell
4/21/2022Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 04/21/2022.
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 04/21/2022.
D
Sell
4/20/2022Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 4/20/2022 due to a significant decline in the total return index, solvency index and volatility index.
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 4/20/2022 due to a significant decline in the total return index, solvency index and volatility index.
D
Sell
11/9/2021Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 11/09/2021.
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D- on 11/09/2021.
D
Sell
11/8/2021Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 11/8/2021 due to a large decline in the efficiency index and valuation index.
AngioDynamics, Inc. (ANGO) was downgraded to D- from D+ on 11/8/2021 due to a large decline in the efficiency index and valuation index.
D
Sell
5/13/2021Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D on 5/13/2021 due to a significant increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.09 to 0.07.
AngioDynamics, Inc. (ANGO) was upgraded to D+ from D on 5/13/2021 due to a significant increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.09 to 0.07.
D
Sell
9/30/2020Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to D from D- on 9/30/2020 due to an increase in the volatility index and total return index.
AngioDynamics, Inc. (ANGO) was upgraded to D from D- on 9/30/2020 due to an increase in the volatility index and total return index.
D
Sell
8/12/2020Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D- from D on 8/12/2020 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 2,651.22% from -$5.71M to -$157.07M, earnings per share declined from -$0.1502 to -$4.1255, and EBIT declined 91.72% from -$4.25M to -$8.15M.
AngioDynamics, Inc. (ANGO) was downgraded to D- from D on 8/12/2020 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 2,651.22% from -$5.71M to -$157.07M, earnings per share declined from -$0.1502 to -$4.1255, and EBIT declined 91.72% from -$4.25M to -$8.15M.
D
Sell
5/20/2020Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D from D+ on 5/20/2020 due to a substantial decline in the growth index, total return index and efficiency index. Operating cash flow declined 400.44% from $5.94M to -$17.84M, EBIT declined 128.97% from -$1.86M to -$4.25M, and net income declined 108.66% from -$2.74M to -$5.71M.
AngioDynamics, Inc. (ANGO) was downgraded to D from D+ on 5/20/2020 due to a substantial decline in the growth index, total return index and efficiency index. Operating cash flow declined 400.44% from $5.94M to -$17.84M, EBIT declined 128.97% from -$1.86M to -$4.25M, and net income declined 108.66% from -$2.74M to -$5.71M.
D
Sell
2/27/2020Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 2/27/2020 due to a decline in the solvency index, total return index and efficiency index. Net income declined 114.59% from -$1.28M to -$2.74M, the quick ratio declined from 2.46 to 1.32, and total capital declined 0.13% from $619.17M to $618.39M.
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 2/27/2020 due to a decline in the solvency index, total return index and efficiency index. Net income declined 114.59% from -$1.28M to -$2.74M, the quick ratio declined from 2.46 to 1.32, and total capital declined 0.13% from $619.17M to $618.39M.
C
Hold
11/15/2019Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 11/15/2019 due to a significant decline in the growth index, volatility index and total return index. Operating cash flow declined 126.12% from $25.01M to -$6.53M, earnings per share declined from $1.54 to -$0.0337, and EBIT declined 97.48% from $8.88M to $224.
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 11/15/2019 due to a significant decline in the growth index, volatility index and total return index. Operating cash flow declined 126.12% from $25.01M to -$6.53M, earnings per share declined from $1.54 to -$0.0337, and EBIT declined 97.48% from $8.88M to $224.
C
Hold
10/8/2019Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C from C+ on 10/8/2019 due to a decline in the total return index and volatility index.
AngioDynamics, Inc. (ANGO) was downgraded to C from C+ on 10/8/2019 due to a decline in the total return index and volatility index.
C
Hold
10/3/2019Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C+ from B- on 10/3/2019 due to a decline in the volatility index and total return index.
AngioDynamics, Inc. (ANGO) was downgraded to C+ from B- on 10/3/2019 due to a decline in the volatility index and total return index.
B
Buy
8/26/2019Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to B- from C+ on 8/26/2019 due to an increase in the total return index and valuation index.
AngioDynamics, Inc. (ANGO) was upgraded to B- from C+ on 8/26/2019 due to an increase in the total return index and valuation index.
C
Hold
8/14/2019Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C+ from D+ on 8/14/2019 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from $0.02 to $1.54, net income increased 7,296.11% from $796 to $58.87M, and operating cash flow increased 199.83% from $8.34M to $25.01M.
AngioDynamics, Inc. (ANGO) was upgraded to C+ from D+ on 8/14/2019 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from $0.02 to $1.54, net income increased 7,296.11% from $796 to $58.87M, and operating cash flow increased 199.83% from $8.34M to $25.01M.
D
Sell
7/15/2019Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 7/15/2019 due to a noticeable decline in the volatility index, total return index and valuation index.
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 7/15/2019 due to a noticeable decline in the volatility index, total return index and valuation index.
C
Hold
5/1/2019Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 5/1/2019 due to a major decline in the total return index.
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 5/1/2019 due to a major decline in the total return index.
C
Hold
4/4/2019Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C from C+ on 4/4/2019 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.0571 to $0.02, net income declined 62.8% from $2.14M to $796, and operating cash flow declined 35.63% from $12.96M to $8.34M.
AngioDynamics, Inc. (ANGO) was downgraded to C from C+ on 4/4/2019 due to a substantial decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.0571 to $0.02, net income declined 62.8% from $2.14M to $796, and operating cash flow declined 35.63% from $12.96M to $8.34M.
C
Hold
3/29/2019Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C+ from C on 3/29/2019 due to a substantial increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0126 to $0.0571, operating cash flow increased 246.05% from -$8.87M to $12.96M, and EBIT increased 46.07% from $4.76M to $6.95M.
AngioDynamics, Inc. (ANGO) was upgraded to C+ from C on 3/29/2019 due to a substantial increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0126 to $0.0571, operating cash flow increased 246.05% from -$8.87M to $12.96M, and EBIT increased 46.07% from $4.76M to $6.95M.
C
Hold
7/25/2018Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 7/25/2018 due to a significant increase in the valuation index, efficiency index and total return index. Total capital increased 0.49% from $631.13M to $634.22M.
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 7/25/2018 due to a significant increase in the valuation index, efficiency index and total return index. Total capital increased 0.49% from $631.13M to $634.22M.
C
Hold
4/23/2018Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C- from D+ on 4/23/2018 due to an increase in the total return index and volatility index.
AngioDynamics, Inc. (ANGO) was upgraded to C- from D+ on 4/23/2018 due to an increase in the total return index and volatility index.
D
Sell
4/6/2018Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 4/6/2018 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 57.55% from $10.17M to $4.32M, and total revenue declined 3.29% from $86.71M to $83.85M.
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 4/6/2018 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 57.55% from $10.17M to $4.32M, and total revenue declined 3.29% from $86.71M to $83.85M.
C
Hold
12/20/2017Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 12/20/2017 due to a decline in the total return index.
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 12/20/2017 due to a decline in the total return index.
C
Hold
12/5/2017Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 12/5/2017 due to an increase in the total return index.
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 12/5/2017 due to an increase in the total return index.
C
Hold
11/20/2017Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 11/20/2017 due to a decline in the total return index.
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 11/20/2017 due to a decline in the total return index.
C
Hold
10/20/2017Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 10/20/2017 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.3523 to -$0.0009.
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 10/20/2017 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.3523 to -$0.0009.
C
Hold
8/7/2017Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C- from D+ on 8/7/2017 due to a major increase in the growth index, efficiency index and volatility index. Operating cash flow increased 32.22% from $14.37M to $18.99M, and total revenue increased 1.53% from $85.6M to $86.91M.
AngioDynamics, Inc. (ANGO) was upgraded to C- from D+ on 8/7/2017 due to a major increase in the growth index, efficiency index and volatility index. Operating cash flow increased 32.22% from $14.37M to $18.99M, and total revenue increased 1.53% from $85.6M to $86.91M.
D
Sell
4/5/2017Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 4/5/2017 due to a major decline in the growth index and valuation index. Earnings per share declined from $0.37 to $0.0788, EBIT declined 6.55% from $7.5M to $7.01M, and operating cash flow declined 3.89% from $14.95M to $14.37M.
AngioDynamics, Inc. (ANGO) was downgraded to D+ from C- on 4/5/2017 due to a major decline in the growth index and valuation index. Earnings per share declined from $0.37 to $0.0788, EBIT declined 6.55% from $7.5M to $7.01M, and operating cash flow declined 3.89% from $14.95M to $14.37M.
C
Hold
1/3/2017Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 1/3/2017 due to a noticeable decline in the total return index and valuation index.
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 1/3/2017 due to a noticeable decline in the total return index and valuation index.
C
Hold
12/27/2016Upgraded
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 12/27/2016 due to an increase in the total return index and volatility index.
AngioDynamics, Inc. (ANGO) was upgraded to C from C- on 12/27/2016 due to an increase in the total return index and volatility index.
C
Hold
12/7/2016Downgrade
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 12/7/2016 due to a decline in the total return index.
AngioDynamics, Inc. (ANGO) was downgraded to C- from C on 12/7/2016 due to a decline in the total return index.
C
Hold
11/22/2016Upgraded
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 11/22/2016 due to a noticeable increase in the total return index and volatility index.
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 11/22/2016 due to a noticeable increase in the total return index and volatility index.
C
Hold
11/7/2016Downgrade
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 11/7/2016 due to a major decline in the total return index.
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 11/7/2016 due to a major decline in the total return index.
C
Hold
10/7/2016Upgraded
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 10/7/2016 due to a major increase in the growth index, total return index and solvency index. EBIT increased 609.4% from $862 to $6.12M, earnings per share increased from -$1.1974 to $0.0358, and the quick ratio increased from 1.3 to 1.36.
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 10/7/2016 due to a major increase in the growth index, total return index and solvency index. EBIT increased 609.4% from $862 to $6.12M, earnings per share increased from -$1.1974 to $0.0358, and the quick ratio increased from 1.3 to 1.36.
C
Hold
9/23/2016Upgraded
AngioDynamics Inc. (ANGO) was upgraded to C- from D+ on 9/23/2016 due to a significant increase in the total return index, volatility index and valuation index.
AngioDynamics Inc. (ANGO) was upgraded to C- from D+ on 9/23/2016 due to a significant increase in the total return index, volatility index and valuation index.
D
Sell
5/2/2016Upgraded
AngioDynamics Inc. (ANGO) was upgraded to D+ from D on 5/2/2016 due to a major increase in the growth index, total return index and efficiency index. Net income increased 274.03% from -$362 to $630, earnings per share increased from -$0.01 to $0.0174, and operating cash flow increased 29.39% from $9.58M to $12.39M.
AngioDynamics Inc. (ANGO) was upgraded to D+ from D on 5/2/2016 due to a major increase in the growth index, total return index and efficiency index. Net income increased 274.03% from -$362 to $630, earnings per share increased from -$0.01 to $0.0174, and operating cash flow increased 29.39% from $9.58M to $12.39M.
D
Sell
3/11/2016Downgrade
AngioDynamics Inc. (ANGO) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the total return index, volatility index and solvency index.
AngioDynamics Inc. (ANGO) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the total return index, volatility index and solvency index.
D
Sell
10/9/2015Downgrade
AngioDynamics Inc. (ANGO) was downgraded to D+ from C- on 10/9/2015 due to a significant decline in the volatility index, growth index and solvency index. Operating cash flow declined 56.51% from $10.81M to $4.7M, EBIT declined 29.38% from $4.43M to $3.13M, and total revenue declined 7.97% from $89.86M to $82.7M.
AngioDynamics Inc. (ANGO) was downgraded to D+ from C- on 10/9/2015 due to a significant decline in the volatility index, growth index and solvency index. Operating cash flow declined 56.51% from $10.81M to $4.7M, EBIT declined 29.38% from $4.43M to $3.13M, and total revenue declined 7.97% from $89.86M to $82.7M.
C
Hold
4/10/2015Downgrade
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 4/10/2015 due to a decline in the growth index, efficiency index and valuation index. Operating cash flow declined 669.68% from -$2.15M to $12.23M, earnings per share declined from $0.0376 to -$0.12, and net income declined 418.54% from $1.34M to -$4.26M.
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 4/10/2015 due to a decline in the growth index, efficiency index and valuation index. Operating cash flow declined 669.68% from -$2.15M to $12.23M, earnings per share declined from $0.0376 to -$0.12, and net income declined 418.54% from $1.34M to -$4.26M.
C
Hold
11/14/2014Upgraded
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 11/14/2014 due to a noticeable increase in the growth index, volatility index and efficiency index. Total capital increased 0.05% from $681.11M to $681.47M.
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 11/14/2014 due to a noticeable increase in the growth index, volatility index and efficiency index. Total capital increased 0.05% from $681.11M to $681.47M.
C
Hold
8/15/2014Downgrade
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 8/15/2014 due to a major decline in the growth index, valuation index and efficiency index. Operating cash flow declined 1,830.48% from -$584 to $10.11M, earnings per share declined from $0.14 to -$0.0424, and net income declined 129.27% from $5.11M to -$1.5M.
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 8/15/2014 due to a major decline in the growth index, valuation index and efficiency index. Operating cash flow declined 1,830.48% from -$584 to $10.11M, earnings per share declined from $0.14 to -$0.0424, and net income declined 129.27% from $5.11M to -$1.5M.
C
Hold
8/11/2014Upgraded
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 8/11/2014 due to an increase in the total return index.
AngioDynamics Inc. (ANGO) was upgraded to C from C- on 8/11/2014 due to an increase in the total return index.
C
Hold
5/27/2014Downgrade
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 5/27/2014 due to a decline in the growth index. Earnings per share declined from -$0.0028 to $0.14, operating cash flow declined 106.9% from $8.46M to -$584, and total revenue declined 0.46% from $87.62M to $87.22M.
AngioDynamics Inc. (ANGO) was downgraded to C- from C on 5/27/2014 due to a decline in the growth index. Earnings per share declined from -$0.0028 to $0.14, operating cash flow declined 106.9% from $8.46M to -$584, and total revenue declined 0.46% from $87.62M to $87.22M.
NASDAQ
04/01/2025 4:00PM Eastern
Quotes delayed
